tirzepatide clinical trial enrollment shows 47% greater weight loss vs. Wegovy Cardiovascular outcomes of semaglutide and

Segn el reciente estudio del Centro Nacional de Epidemiologa del Instituto de Salud Carlos III (ISCIII), un 55,8% de la poblacin espaola mayor de edad presenta exceso de peso, un porcentaje que se sita en un 18,7% si nos referimos en exclusiva a la obesidad

Read the full narrative on Hims & Hers Health (it's free!) Hims & Hers Health's narrative projects $3.6 billion revenue and $248.5 million earnings by 2029

Key Consumer and Product Trends Consumer preferences are shifting towards more sophisticated and transparent product offerings

GLP-1 receptor agonists are drugs that mimic the function of glucagon-like peptide-1 (GLP-1), a hormone produced in the gut that has multiple roles in regulating blood sugar levels and appetite